Results 41 to 50 of about 444,660 (199)

Acute and Recurrent Pericarditis

open access: yesCardiology Clinics, 2017
Acute and recurrent pericarditis is the most common pericardial syndrome encountered in clinical practice either as an isolated process or as part of a systemic disease. The diagnosis is based on clinical evaluation, electrocardiogram, and echocardiography.
Imazio M, Gaita F
openaire   +4 more sources

Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome

open access: yesBMC Cardiovascular Disorders, 2019
Background Colchicine has been used as anti-inflammatory agent in pericardial effusion (PE). We sought to perform a meta-analysis of randomized trials assessing the efficacy and safety of colchicine in patients with pericarditis or postpericardiotomy ...
Leon L. Lutschinger   +6 more
doaj   +1 more source

The role of endocarditis, myocarditis and pericarditis in qualitative and quantitative data analysis [PDF]

open access: yes, 2009
The current study is the first scientometric analysis of research activity and output in the field of inflammatory disorders of the heart (endo-, myo- and pericarditis).
Mache, Stefanie   +9 more
core   +1 more source

Expanding the Patient Pool for Rilonacept

open access: yesJACC: Case Reports
Recurrent pericarditis complicates 15%-30% of acute pericarditis cases despite initial anti-inflammatory treatment. The RHAPSODY trial (Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis) showed ...
Emma St. John, MD   +9 more
doaj   +1 more source

Recurrent Pericarditis [PDF]

open access: yesCirculation, 2005
Recurrence is a serious complication of acute pericarditis, characterized by a return of pericardial pain after recovery from an attack of typical acute pericarditis. Some patients experience only a single recurrence, but in many less fortunate, pericardial pain returns unexpectedly at variable intervals during a period that may extend over many years.
openaire   +1 more source

Novel Pathophysiological, Diagnostic and Therapeutic Concepts in Acute and Recurrent Pericarditis

open access: yesReviews in Cardiovascular Medicine, 2023
Acute pericarditis is the most frequent pericardial disease characterized by inflammation of the pericardial layers resulting in pain, dyspnea and fatigue.
Aldo Bonaventura   +8 more
doaj   +1 more source

Recurrent pericarditis : new and emerging therapeutic options

open access: yes, 2016
Recurrent pericarditis is one of the most common and troublesome complications after an episode of pericarditis, and affects 20-50% of patients treated for pericarditis.
Imazio M.   +3 more
core   +2 more sources

Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (Anakinra)

open access: yesНаучно-практическая ревматология, 2023
Pericarditis, a clinical syndrome characterized by inflammation and thickening of the pericardium, is one of the most common forms of inflammatory diseases of the cardiovascular system.
E. L. Nasonov   +3 more
doaj   +1 more source

Severe ADEM‐Like Neuroinflammatory Disease and Cerebrovascular Fragility With Recurrent Pseudoaneurysms and Moyamoya in a Familial Germline CBL Mutation: Expanding the Clinical Phenotype

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Heterozygous germline variants in CBL disrupt its function as a negative regulator of the Ras/MAPK pathway, classically predisposing to Juvenile myelomonocytic leukemia (JMML) and moyamoya. We describe two affected siblings carrying a paternally inherited CBL variant (c.1210 T> C, p.
Michal Bar‐Hakim   +12 more
wiley   +1 more source

The clinical course of patients with previous acute and recurrent pericarditis receiving the BNT162b2 vaccine

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2022
Background: Vaccines against SARS-COV2 have been crucial in efforts against COVID19, yet there have been reports of pericarditis following vaccination with mRNA-based vaccines.
Yishay Wasserstrum   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy